These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 28608389)

  • 1. Sample size planning of two-arm superiority and noninferiority survival studies with discrete follow-up.
    Wellek S
    Stat Med; 2017 Sep; 36(20):3123-3136. PubMed ID: 28608389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimation of parametric failure time distributions based on interval-censored data with irregular dependent follow-up.
    Zhu Y; Lawless JF; Cotton CA
    Stat Med; 2017 May; 36(10):1548-1567. PubMed ID: 28132401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multilevel modelling of clustered grouped survival data using Cox regression model: an application to ART dental restorations.
    Wong MC; Lam KF; Lo EC
    Stat Med; 2006 Feb; 25(3):447-57. PubMed ID: 16143989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simulation program for estimating statistical power of Cox's proportional hazards model assuming no specific distribution for the survival time.
    Akazawa K; Nakamura T; Moriguchi S; Shimada M; Nose Y
    Comput Methods Programs Biomed; 1991 Jul; 35(3):203-12. PubMed ID: 1935013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A U-statistics based approach to sample size planning of two-arm trials with discrete outcome criterion aiming to establish either superiority or noninferiority.
    Wellek S
    Stat Med; 2017 Feb; 36(5):799-812. PubMed ID: 27878839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sample size planning for survival prediction with focus on high-dimensional data.
    Götte H; Zwiener I
    Stat Med; 2013 Feb; 32(5):787-807. PubMed ID: 22859340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Power and sample size calculations for interval-censored survival analysis.
    Kim HY; Williamson JM; Lin HM
    Stat Med; 2016 Apr; 35(8):1390-400. PubMed ID: 26643411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sample size calculation for studies with grouped survival data.
    Li Z; Wang X; Wu Y; Owzar K
    Stat Med; 2018 Nov; 37(27):3904-3917. PubMed ID: 29888484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validity and efficiency of approximation methods for tied survival times in Cox regression.
    Hertz-Picciotto I; Rockhill B
    Biometrics; 1997 Sep; 53(3):1151-6. PubMed ID: 9333345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heteroscedastic transformation cure regression models.
    Chen CM; Chen CH
    Stat Med; 2016 Jun; 35(14):2359-76. PubMed ID: 26887342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing the consistency of the treatment effect under the discrete random effects model in multiregional clinical trials.
    Liu JT; Tsou HH; Gordon Lan KK; Chen CT; Lai YH; Chang WJ; Tzeng CS; Hsiao CF
    Stat Med; 2016 Jun; 35(14):2301-14. PubMed ID: 26833851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interpretable inference on the mixed effect model with the Box-Cox transformation.
    Maruo K; Yamaguchi Y; Noma H; Gosho M
    Stat Med; 2017 Jul; 36(15):2420-2434. PubMed ID: 28294388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The analysis of very small samples of repeated measurements I: an adjusted sandwich estimator.
    Skene SS; Kenward MG
    Stat Med; 2010 Nov; 29(27):2825-37. PubMed ID: 20839367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regression models for the restricted residual mean life for right-censored and left-truncated data.
    Cortese G; Holmboe SA; Scheike TH
    Stat Med; 2017 May; 36(11):1803-1822. PubMed ID: 28106926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A sample size planning approach that considers both statistical significance and clinical significance.
    Jia B; Lynn HS
    Trials; 2015 May; 16():213. PubMed ID: 25962998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Testing and interval estimation for two-sample survival comparisons with small sample sizes and unequal censoring.
    Wang R; Lagakos SW; Gray RJ
    Biostatistics; 2010 Oct; 11(4):676-92. PubMed ID: 20439258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Semiparametric regression analysis of failure time data with dependent interval censoring.
    Chen CM; Shen PS
    Stat Med; 2017 Sep; 36(21):3398-3411. PubMed ID: 28585322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sample size calculations for noninferiority trials with Poisson distributed count data.
    Stucke K; Kieser M
    Biom J; 2013 Mar; 55(2):203-16. PubMed ID: 23401289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of different parametric proportional hazards models for interval-censored data: a simulation study.
    Gong Q; Fang L
    Contemp Clin Trials; 2013 Sep; 36(1):276-83. PubMed ID: 23916917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Instrumental variable with competing risk model.
    Zheng C; Dai R; Hari PN; Zhang MJ
    Stat Med; 2017 Apr; 36(8):1240-1255. PubMed ID: 28064466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.